639 followers
Advances in GLP-1 treatment: focus on oral semaglutide. Oral semaglutide effectively reduces glycated hemoglobin (HbA1c) levels and body weight in a broad spectrum of patients with T2D and shows cardiovascular safety. https://t.co/nyPfpfpLIN